The development of the ANTI-RICIN aerosol: a success-story reported by the press

Anti-ricin device presented by DGA in the exposition hall at the Eurosatory congress (French Army congress) in July-16.

ANTI-RICIN aerosol is the result of 3 years of a collaboration between DGA & its Health deparment (French Army), the CEPR specialized on aerosol and biomedicine (Inserm unity) and Aerodrug (DTF aerosoltherapy R&D department) specialized on aerosol technology and devices.
The research project (initially named AERORIMAC) was conducted to develop an efficient treatment against ricine exposure from the anti-ricine antibody molecule provided by the army Health depatment.
This project was a "Dual" PUBLIC-french ARMY project with RAPID financial support.

The differents steps of the work process, from the galenic & the development of the aerosol device to the validation of pulmonary administration, is today reported by press : view the French reportage TV info (France 5).

Related article:
- Respaud R, Marchand D, Pelat T, Tchou-Wong KM, Roy CJ, Parent C, Cabrera M, Guillemain J, Mac Loughlin R, Levacher E, Fontayne A, Douziech-Eyrolles L, Junqua-Moullet A, Guilleminault L, Thullier P, Guillot-Combe E, Vecellio L, Heuzé-Vourc’h N. Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin -J Control Release. 2016 Jul 28;234:21-32. doi: 10.1016/j.jconrel.2016.05.018. Epub 2016 May 9.
Read the article


- The DGA, The French Army and its Health department
- DTF, The diffusion Technique Française (Saint Etienne, FR)
- The research Center of Respiratory Diseases (CEPR- UMR INSERM 1100, Tours, FR)
Aerodrug, Faculté de Médecine, Bâtiment M, 10 ter boulevard Tonnellé, 37032 TOURS France.